Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.

Aims: To analyse the follow-up data of implantable cardioverter-defibrillator (ICD) therapy in Brugada syndrome (BS).

Methods And Results: We conducted a retrospective, single centre study of 47 patients (mean age: 44.5 +/- 15 years) with BS, who underwent primary prophylactic ICD implantation.